Symbols / MSOS
MSOS Chart
About
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | 0.00% |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | 7.25 | 52W Low | 2.02 |
| Beta | — | Avg Volume | 11.62M | Volume | 9.72M |
| Target Price | — | Recom | — | Prev Close | $3.65 |
| Price | $3.98 | Change | 9.04% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
No analyst ratings or price targets available.
- MSOS: Focused Exposure To U.S. Cannabis Stocks - Seeking Alpha Mon, 19 Jan 2026 08
- Best Cannabis ETFs to Buy in 2026 and How to Invest in Them - The Motley Fool hu, 12 Feb 2026 08
- MSOS ETF Drops 26% in One Month as Federal Cannabis Policy Stalls - Yahoo Finance Sun, 18 Jan 2026 08
- MSOS Limps Into 2026 - New Cannabis Ventures hu, 08 Jan 2026 08
- What a new federal cannabis order could mean for 400,000 workers - Stock Titan hu, 18 Dec 2025 08
- AdvisorShares Pure US Cannabis ETF (MSOS) Top 25 Holdings - TIKR.com Sat, 04 Oct 2025 07
- Marijuana rescheduling could mean more investment in US weed stocks. There aren’t many ways in. - Sherwood News Fri, 19 Dec 2025 08
- From Loss to Lift-Off: Marijuana ETFs Rebound on Legalization Prospects - Zacks Investment Research Mon, 06 Oct 2025 07
- Interesting MSOS Put Options For February 2026 - Nasdaq Wed, 08 Oct 2025 07
- Cannabis Stocks: President Trump Signs Executive Order Directing US Government to Reschedule - Morningstar Canada Fri, 19 Dec 2025 08
- Cannabis stocks surge on Trump reclassification hopes - 조선일보 Wed, 17 Dec 2025 08
- Cannabis stocks rally on rescheduling hopes (MSOS:NYSEARCA) - Seeking Alpha Sat, 13 Dec 2025 08
- Tilray Is a Dangerous Stock - New Cannabis Ventures Wed, 20 Aug 2025 07
- Trump's Marijuana Reclassification Looks Set To Send This Cannabis ETF Soaring: Big Surge In Momentum - Yahoo Finance Sun, 21 Dec 2025 08
- The Big MSO to Buy - New Cannabis Ventures hu, 28 Aug 2025 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for MSOS
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|